Publications by authors named "T Valerio"
Candy Cane Hypopyon Secondary to Intraocular Mantle Cell Lymphoma: A Case Report.
Case Rep Ophthalmol
December 2024
Introduction: Bilateral hemorrhagic hypopyon, also known as candy cane hypopyon, is an extremely rare presentation which we report as a unique case in association with intraocular mantle cell lymphoma (MCL).
Case Presentation: A 63-year-old white male presented with a 3-week history of conjunctival injection OS that was unresponsive to erythromycin ointment and topical steroids, in the setting of recently discovered diffuse lymphadenopathy and malaise. On presentation, he was found to have bilateral hemorrhagic hypopyon.
Article Synopsis
- - This study conducted a sensitivity analysis on a trapeziometacarpal joint model using 675 finite element simulations that combined various morphologies, joint stiffness, and grip strategies to assess joint pressure.
- - Results showed that the variability in joint pressure was primarily influenced by the joint's morphology rather than grip strategy or stiffness.
- - A notable relationship was established between the curvature of the trapezium bone and joint pressure, emphasizing the significance of morphology for accurately estimating joint contact pressure.
Gamma delta T cells (γδT cells) play crucial roles in the immune response against tumors, yet their functional dynamics under different cancer therapies remain poorly understood. Laser Ablative Immunotherapy (LAIT) is a novel cancer treatment modality combining local photothermal therapy (PTT) and intratumoral injection of an immunostimulant, N-dihydrogalactochitosan (glycated chitosan, GC). LAIT has been shown to induce systemic antitumor immune responses in pre-clinical studies and clinical trials, eradicating both treated local tumors and untreated distant metastases.
View Article and Find Full Text PDFPurpose: To report a case of Cogan-Like Syndrome following treatment with nivolumab for metastatic cutaneous melanoma.
Methods: A case report.
Results: A 54-year-old female sought a second opinion from us regarding the recently diagnosed uveitis in both eyes.
Purpose: To evaluate outcomes of intravenous (IV) tocilizumab (TCZ) in patients with pars planitis refractory to conventional immunomodulatory therapy and anti-tumor necrosis factor (TNF) alpha agents.
Methods: Medical records of eight patients diagnosed with pars planitis and treated with monthly 4 or 8 mg/kg IV TCZ were reviewed. The primary objective was to initiate and sustain remission continuously for three consecutive months.